Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYK | P43405 | 1/20 | 0.64 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.61 |
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | CTSL | P07711 | 6/20 | 0.53 |
| ▸ | CTSS | P25774 | 6/20 | 0.53 |
| ▸ | CTSK | P43235 | 5/20 | 0.53 |
| ▸ | CTSB | P07858 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | ELANE | P08246 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11528148 | 1.00 | SYK (0.64) | SYKCTRB1ATMCTSLCTSS | |
| SCHEMBL213314 | 1.00 | SYK (0.64) | SYKCTRB1ATMCTSLCTSS | |
| Acetic Acid SCHEMBL9810154 | 0.97 | SYK (0.62) | SYKCTRB1ATMCTSLCTSS | |
| SCHEMBL12220545 | 0.92 | SYK (0.69) | SYKCTRB1ATMCTSLCTSS | |
| SCHEMBL4829896 | 0.91 | CTRB1 (0.68) | SYKCTRB1ATMCTSLCTSS | |
| SCHEMBL15271597 | 0.88 | CTRB1 (0.58) | SYKCTRB1ATMCTSLCTSS | |
| SCHEMBL21906489 | 0.88 | CTRB1 (0.58) | SYKCTRB1ATMCTSLCTSS | |
| SCHEMBL28366233 | 0.88 | CTRB1 (0.58) | SYKCTRB1ATMCTSLCTSS | |
| SCHEMBL8900969 | 0.88 | CTRB1 (0.74) | SYKCTRB1ATMCTSLCTSS | |
| SCHEMBL14595243 | 0.88 | CTRB1 (0.74) | SYKCTRB1ATMCTSLCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12110308-B2 | Phosphor(n)amidatacetal and phosph(on)atalcetal compounds | NUCORION PHARMACEUTICALS, INC. (US) | 2024-10-08 | — | — | US | disclosed |
| EP-4335496-A2 | PHOSPHOR(N)AMIDATACETAL AND PHOSPH(ON)ATALCETAL COMPOUNDS | NUCORION PHARMACEUTICALS, INC. (US) | 2024-03-13 | — | — | EP | disclosed |
| CN-117402189-A | Phosphoramidate (phosphonate) acetals and phospho (phosphonate) acetal compounds | 广东集宝医药技术有限公司 | 2024-01-16 | — | — | CN | disclosed |
| CN-111836818-B | Phosphoramidate (phosphonate) acetals and phospho (phosphonate) acetal compounds | 纽科利制药公司 | 2023-10-31 | — | — | CN | disclosed |
| EP-3395796-B1 | A CRYSTALLINE TRIHYDRATE FORM OF (3S,3S') 4,4'-DISULFANEDIYLBIS (3-AMINOBUTANE 1-SULFONIC ACID) | QUANTUM GENOMICS (FR) | 2021-11-24 | — | — | EP | disclosed |
| US-20210188887-A1 | PHOSPHOR(N)AMIDATACETAL AND PHOSPH(ON)ATALCETAL COMPOUNDS | NUCORION PHARMACEUTICALS, INC. | 2021-06-24 | — | — | US | disclosed |
| EP-3752511-A1 | PHOSPHOR(N)AMIDATACETAL AND PHOSPH(ON)ATALCETAL COMPOUNDS | NUCORION PHARMACEUTICALS, INC. (US) | 2020-12-23 | — | — | EP | disclosed |
| CN-111836818-A | Aminophosphoric acid acetal and phosphono (phosphonic) acid acetal compounds | 纽科利制药公司 | 2020-10-27 | — | — | CN | disclosed |
| EP-3395796-A1 | A CRYSTALLINE TRIHYDRATE FORM OF (3S,3S ) 4,4 -DISULFANEDIYLBIS (3-AMINOBUTANE 1-SULFONIC ACID) | Quantum Genomics (FR) | 2018-10-31 | — | — | EP | disclosed |
| US-9340497-B2 | Method for the preparation of (3S,3S′) 4,4′-disulfanediylbis (3-aminobutane 1-sulfonic acid) | QUANTUM GENOMICS (FR) | 2016-05-17 | — | — | US | disclosed |
| EP-2625163-A1 | METHOD FOR THE PREPARATION OF (3S,3S') 4,4'-DISULFANEDIYLBIS (3-AMINOBUTANE 1-SULFONIC ACID) | Quantum Genomics (FR) | 2013-08-14 | — | — | EP | disclosed |
| WO-2012045849-A1 | METHOD FOR THE PREPARATION OF (3S,3S') 4,4'-DISULFANEDIYLBIS (3-AMINOBUTANE 1-SULFONIC ACID) | QUANTUM GENOMICS (FR) | 2012-04-12 | — | — | WO | disclosed |
| CN-101215288-A | Novel beta-lactam compounds and process for producing the same | DAINIPPON SUMITOMO PHARMA CO (JP) | 2008-07-09 | — | — | CN | disclosed |
| CN-100379738-C | Novel beta-lactam compound and process for producing the same | SUMITOMO PHARMA (JP) | 2008-04-09 | — | — | CN | disclosed |
| EP-1287006-B1 | ANTITUMORAL COMPOUNDS | PHARMA MAR SA (ES) | 2007-10-24 | — | — | EP | disclosed |
| US-7138547-B2 | Antitumoral compounds | PHARMA MAR, S.A. | 2006-11-21 | — | — | US | disclosed |
| CN-1484645-A | Novel beta-lactam compound and process for producing the same | ס����ҩ��ʽ���� | 2004-03-24 | — | — | CN | disclosed |
| US-20040048834-A1 | Antitumoral compounds | PHARMA MAR, S.A. (ES) | 2004-03-11 | — | — | US | disclosed |
| EP-0222561-B1 | PROCESS FOR ENZYMATIC SEPARATION OF OPTICAL ISOMERS OF 2-AMINOBUTANOL | Montedison S.p.A. (IT) | 1991-05-08 | — | — | EP | disclosed |
| EP-0222561-A2 | Process for enzymatic separation of optical isomers of 2-aminobutanol | Montedison S.p.A. (IT) | 1987-05-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040048834-A1 | Antitumoral compounds | HCCS, MSR1, SUCNR1 | SYK 2311/4885CTRB1 3693/4885ATM 3873/4885 |
| US-12110308-B2 | Phosphor(n)amidatacetal and phosph(on)atalcetal compounds | PYGL, MTMR1, PTEN | SYK 1979/4885CTRB1 2414/4885ATM 758/4885 |
| US-20210188887-A1 | PHOSPHOR(N)AMIDATACETAL AND PHOSPH(ON)ATALCETAL COMPOUNDS | PYGL, MTMR1, PTEN | SYK 2299/4885CTRB1 2345/4885ATM 538/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.